Advanced anticancer drug, ¡®Genexol¡¯ will start a phase II clinical trial. For this trial, medical division of Samyang Co. will raise the fifty patients suffering from metastatic breast cancer, and will do the clinical test in Seoul National University hospital, Samsung medical center, Severance hospital of Yonsei university and Donga university hospital in Pusan.
News
